Subcutaneous immunoglobulin replacement therapy with Hizentra®, the first 20% SCIG preparation: a Practical approach

Local tolerance and stability up to 24 months of a new 20% proline-stabilized polyclonal immunoglobulin for subcutaneous administration

(2011) Werner Maeder et al.   BIOLOGICALS

Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies

(2011) M. Borte et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Pharmacokinetics of Subcutaneous IgPro20 in Patients with Primary Immunodeficiency

(2011) Richard L. Wasserman et al.   CLINICAL PHARMACOKINETICS

The Construction of a Pharmacokinetic Model to Describe Intravenous and Subcutaneous Supplementation of IgG in Patients with Primary Immunodeficiency (PID)

(2011) M. Bexon et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Improved Quality of Life, Immunoglobulin G Levels, and Infection Rates in Patients with Primary Immunodeficiency Diseases during Self-Treatment with Subcutaneous Immunoglobulin G

(2011) Melvin Berger et al.   SOUTHERN MEDICAL JOURNAL

Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century

(2010) Meredith L. Moore et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Subcutaneous immunoglobulin in polymyositis and dermatomyositis: A novel application

(2010) Maria Giovanna Danieli et al.   AUTOIMMUNITY REVIEWS

The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions

(2010) A. GARDULF et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies

(2010) Jordan S. Orange et al.   CLINICAL IMMUNOLOGY

Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency

(2010) John B. Hagan et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Subcutaneous Immunoglobulin Therapy by Rapid Push is Preferred to Infusion by Pump: A Retrospective Analysis

(2010) Ralph Shapiro   JOURNAL OF CLINICAL IMMUNOLOGY

Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy

(2010) T. Harbo et al.   NEUROLOGY

l-Proline reduces IgG dimer content and enhances the stability of intravenous immunoglobulin (IVIG) solutions

(2009) Reinhard Bolli et al.   BIOLOGICALS

Clinical applications of intravenous immunoglobulins in neurology

(2009) R. A. C. Hughes et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial

(2009) T. Harbo et al.   EUROPEAN JOURNAL OF NEUROLOGY

Effective Use of Subcutaneous Immune Globulin (SCIG) for an Infant with X-linked Agammaglobulinemia (X-LA)

(2009) C.M. Duff et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Primary immunodeficiencies: 2009 update

(2009) Luigi D. Notarangelo et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Efficacy, Pharmacokinetics, Safety, and Tolerability of Flebogamma® 10% DIF, a High-Purity Human Intravenous Immunoglobulin, in Primary Immunodeficiency

(2009) Melvin Berger et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Subcutaneous immunoglobulin therapy for multifocal motor neuropathy

(2009) Filip Eftimov et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Investigations of prion and virus safety of a new liquid IVIG product

(2008) M. Stucki et al.   BIOLOGICALS

Subcutaneous Administration of IgG

(2008) Melvin Berger   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy

(2007) A. Gardulf et al.   CLINICAL IMMUNOLOGY